Annual Current Liabilities
$36.94 M
+$21.51 M+139.39%
December 31, 2023
Summary
- As of February 25, 2025, TARS annual total current liabilities is $36.94 million, with the most recent change of +$21.51 million (+139.39%) on December 31, 2023.
- During the last 3 years, TARS annual current liabilities has risen by +$31.55 million (+585.65%).
- TARS annual current liabilities is now at all-time high.
Performance
TARS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$65.87 M
+$14.30 M+27.72%
September 30, 2024
Summary
- As of February 25, 2025, TARS quarterly total current liabilities is $65.87 million, with the most recent change of +$14.30 million (+27.72%) on September 30, 2024.
- Over the past year, TARS quarterly current liabilities has stayed the same.
- TARS quarterly current liabilities is now at all-time high.
Performance
TARS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TARS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +139.4% | 0.0% |
| 3 y3 years | +585.6% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
TARS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +221.8% | at high | +473.9% |
| 5 y | 5-year | at high | +4409.9% | at high | +7942.5% |
| alltime | all time | at high | >+9999.0% | at high | +7942.5% |
Tarsus Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.87 M(+27.7%) |
| Jun 2024 | - | $51.57 M(+21.3%) |
| Mar 2024 | - | $42.53 M(+15.1%) |
| Dec 2023 | $36.94 M(+139.4%) | $36.94 M(+58.9%) |
| Sep 2023 | - | $23.25 M(+57.5%) |
| Jun 2023 | - | $14.77 M(+11.4%) |
| Mar 2023 | - | $13.26 M(-14.1%) |
| Dec 2022 | $15.43 M | $15.43 M(+8.1%) |
| Sep 2022 | - | $14.27 M(+21.8%) |
| Jun 2022 | - | $11.72 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $12.61 M(+9.9%) |
| Dec 2021 | $11.48 M(+113.1%) | $11.48 M(+10.7%) |
| Sep 2021 | - | $10.37 M(-0.9%) |
| Jun 2021 | - | $10.46 M(+3.3%) |
| Mar 2021 | - | $10.12 M(+87.8%) |
| Dec 2020 | $5.39 M(+557.8%) | $5.39 M(-12.3%) |
| Sep 2020 | - | $6.14 M(+99.8%) |
| Jun 2020 | - | $3.08 M(+275.5%) |
| Dec 2019 | $819.00 K(+357.5%) | $819.00 K |
| Dec 2018 | $179.00 K | - |
FAQ
- What is Tarsus Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual current liabilities year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly current liabilities year-on-year change?
What is Tarsus Pharmaceuticals annual total current liabilities?
The current annual current liabilities of TARS is $36.94 M
What is the all time high annual current liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total current liabilities is $36.94 M
What is Tarsus Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, TARS annual total current liabilities has changed by +$21.51 M (+139.39%)
What is Tarsus Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of TARS is $65.87 M
What is the all time high quarterly current liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total current liabilities is $65.87 M
What is Tarsus Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, TARS quarterly total current liabilities has changed by $0.00 (0.00%)